Sign in
4

Changes in Ownership

Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-071014

President, CEO sold 25,000 shares at an average $44.18 ($1,104,411)

  • President, CEO acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jacobs John C President, CEO 2022-06-13 Option exercise +25,000 $8.22 $205,500 25,000 D: show line 1 in the form
Jacobs John C President, CEO 2022-06-13 Sale −9,803 $43.63 $427,735 15,197 D: show line 2 in the form
Jacobs John C President, CEO 2022-06-13 Sale −15,197 $44.53 $676,675 0 D: show line 3 in the form
Open-market sales · 25,000 sh · avg $44.18 · $1,104,411

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jacobs John C President, CEO 2022-06-13 Option exercise · Stock Option −25,000 169,751 D: show line 4 in the form
Loading xslF345X03/tm2218405-1_4seq1.xml…